Matthew Foster

Chief Restructuring Officer at Argos Therapeutics, Inc.

Matthew Foster

Matthew Foster

Chief Restructuring Officer at Argos Therapeutics, Inc.

Biography

Mr. Matthew Foster is a Chief Restructuring Officer at Argos Therapeutics, Inc.

Overview
RelSci Relationships

53

Relationships
RelSci Relationships are individuals Matthew Foster likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Novadip Biosciences SA

Relationship likelihood: Strong

Venture Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Operating Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Director Quality Assurance at Argos Therapeutics, Inc.

Relationship likelihood: Average

Former Chief Financial & Business Officer at Viamet Pharmaceuticals Corp.

Relationship likelihood: Average

Adjunct Professor of Business Management & Marketing at The University of North Carolina at Wilmington

Relationship likelihood: Average

President & Chief Executive Officer at UbiVac LLC

Relationship likelihood: Average

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Relationship likelihood: Average

Member, Scientific Advisory Board at Argos Therapeutics, Inc.

Relationship likelihood: Average

Paths to Matthew Foster
Potential Connections via
Relationship Science
You
Matthew Foster
Chief Restructuring Officer at Argos Therapeutics, Inc.
Career History
Chief Restructuring Officer
2018 - Current

Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.

Other Affiliations

Matthew Foster is affiliated with Argos Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew Foster. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew Foster's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew Foster.